Prana Biotechnology Ltd Sponsored ADR
(NASDAQ : PRAN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading PRAN News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.28%72.671.2%$696.83m
CELGCelgene Corporation
-4.70%111.871.3%$645.43m
AMGNAmgen Inc.
-3.40%140.171.0%$605.61m
BIIBBiogen Inc.
-2.33%284.381.2%$526.97m
REGNRegeneron Pharmaceuticals, Inc.
-2.85%358.453.6%$382.78m
ALXNAlexion Pharmaceuticals, Inc.
0.73%125.071.9%$363.71m
ILMNIllumina, Inc.
-3.51%121.963.0%$177.14m
VRTXVertex Pharmaceuticals Incorporated
-3.11%75.692.9%$164.83m
INCYIncyte Corporation
-3.79%103.152.4%$161.54m
TSROTESARO, Inc.
-2.60%136.2417.1%$156.34m
IONSIonis Pharmaceuticals, Inc.
-3.52%45.7810.0%$147.58m
EXELExelixis, Inc.
-9.21%16.576.4%$116.16m
BMRNBioMarin Pharmaceutical Inc.
-1.84%81.474.5%$114.14m
BLUEBluebird Bio, Inc.
-9.44%71.5023.3%$112.20m
AAgilent Technologies, Inc.
-0.07%44.811.6%$111.54m

Company Profile

Prana Biotechnology Ltd. engages in the development of therapies to treat neurodegenerative disease. It includes research and development of treatments for Alzheimer's and Huntington's disease. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.